Nightscout is a great initiative. Monitoring of type 2 is rapidly improving, especially as CGMs aren’t restricted to type 1s on insurance as much as they sued t

Nightscout is a great initiative. Monitoring of type 2 is rapidly improving, especially as CGMs aren’t restricted to type 1s on insurance as much as they sued to be. Increasing the market size of CGMs has led to significant competition. Thought on treating type 2 is also evolving in ways that don’t benefit type 1 as much. For example, the trend is for pre-diabetes to be taken seriously and detected earlier.